# Vyalev

NDC: 0074-0501
Generic name: foscarbidopa/foslevodopa
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20220412

FDA application: NDA216962

## Active ingredients

- FOSCARBIDOPA: 12 mg/mL
- FOSLEVODOPA: 240 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-0501"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-0501
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28e806e4-951c-40a9-9f0c-d0929caf054c